Literature DB >> 8512624

Effects of acute stimulant medication on cerebral metabolism in adults with hyperactivity.

J A Matochik1, T E Nordahl, M Gross, W E Semple, A C King, R M Cohen, A J Zametkin.   

Abstract

Recent work in our laboratory has demonstrated both global and regional reductions in cerebral glucose metabolism in adult subjects with attention-deficit hyperactivity disorder (ADHD). The purpose of the present study was to examine the effects of an acute dose of stimulant medication on cerebral metabolism in adults with ADHD using positron emission tomography with fluorodeoxyglucose-18 as the tracer. Each subject underwent scanning twice, once off-drug and again after receiving a single oral dose of either dextroamphetamine (0.25 mg/kg) or methylphenidate (0.35 mg/kg). Subjects completed behavioral self-report measures before and after the scan and performed an auditory continuous performance task during the tracer uptake period. Neither drug changed global metabolism. Both drugs increased systolic blood pressure, and dextroamphetamine improved performance on the auditory attention task. Each stimulant produced a differential pattern of increases and decreases in regional metabolism throughout the regions of interest that were sampled. Rather than increasing glucose utilization in specific brain regions with lowered metabolic rates in adults with ADHD, stimulants may act by altering glucose use throughout the brain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8512624     DOI: 10.1038/npp.1993.38

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  11 in total

1.  Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.

Authors:  Michael Michaelides; Javier Pascau; Juan-Domingo Gispert; Foteini Delis; David K Grandy; Gene-Jack Wang; Manuel Desco; Marcelo Rubinstein; Nora D Volkow; Panayotis K Thanos
Journal:  Eur J Neurosci       Date:  2010-07-16       Impact factor: 3.386

Review 2.  Neuropsychiatric effects of prescription drug abuse.

Authors:  Jason P Caplan; Lucy A Epstein; Davin K Quinn; Jonathan R Stevens; Theodore A Stern
Journal:  Neuropsychol Rev       Date:  2007-08-16       Impact factor: 7.444

3.  The effects of stimulant medication on working memory functional connectivity in attention-deficit/hyperactivity disorder.

Authors:  Christina G Wong; Michael C Stevens
Journal:  Biol Psychiatry       Date:  2011-12-29       Impact factor: 13.382

Review 4.  [Functional imaging of neurocognitive dysfunction in attention deficit hyperactivity disorder].

Authors:  I Wolf; H Tost; M Ruf; M H Schmidt; G Ende
Journal:  Radiologe       Date:  2005-02       Impact factor: 0.635

Review 5.  Pharmacologic treatment of attention-deficit/hyperactivity disorder: efficacy, safety and mechanisms of action.

Authors:  Steven R Pliszka
Journal:  Neuropsychol Rev       Date:  2007-03       Impact factor: 7.444

6.  Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder.

Authors:  Katherine N Hewitt; Yasmene B Shah; Malcolm J W Prior; Peter G Morris; Chris P Hollis; Kevin C F Fone; Charles A Marsden
Journal:  Psychopharmacology (Berl)       Date:  2005-04-28       Impact factor: 4.530

7.  Amphetamine Modestly Improves Conners' Continuous Performance Test Performance in Healthy Adults.

Authors:  David A MacQueen; Arpi Minassian; Brook L Henry; Mark A Geyer; Jared W Young; William Perry
Journal:  J Int Neuropsychol Soc       Date:  2017-10-16       Impact factor: 2.892

Review 8.  Attention-deficit/hyperactivity disorder and attention networks.

Authors:  George Bush
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

9.  The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder.

Authors:  Claudia M Szobot; Carla Ketzer; Renato D Cunha; Maria A Parente; Daniel D Langleben; Paul D Acton; Flávio Kapczinski; Luis A P Rohde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-11       Impact factor: 9.236

Review 10.  Neurobiology of hedonic tone: the relationship between treatment-resistant depression, attention-deficit hyperactivity disorder, and substance abuse.

Authors:  Tia Sternat; Martin A Katzman
Journal:  Neuropsychiatr Dis Treat       Date:  2016-08-25       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.